"Hypertriglyceridemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition of elevated levels of TRIGLYCERIDES in the blood.
| Descriptor ID |
D015228
|
| MeSH Number(s) |
C18.452.584.500.500.851
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypertriglyceridemia".
Below are MeSH descriptors whose meaning is more specific than "Hypertriglyceridemia".
This graph shows the total number of publications written about "Hypertriglyceridemia" by people in this website by year, and whether "Hypertriglyceridemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 2 | 3 |
| 2011 | 4 | 1 | 5 |
| 2012 | 1 | 2 | 3 |
| 2013 | 5 | 1 | 6 |
| 2014 | 2 | 1 | 3 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 2 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 4 | 2 | 6 |
| 2020 | 0 | 2 | 2 |
| 2021 | 5 | 2 | 7 |
| 2022 | 10 | 0 | 10 |
| 2023 | 3 | 0 | 3 |
| 2024 | 5 | 1 | 6 |
| 2025 | 4 | 0 | 4 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypertriglyceridemia" by people in Profiles.
-
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial. Nat Med. 2026 Apr; 32(4):1432-1443.
-
Screening, Diagnosis, and Management of Pediatric Hypertriglyceridemia: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2026 Apr; 46(4):e000195.
-
Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice. Nat Commun. 2026 Jan 03; 17(1):1458.
-
Targeting Triglycerides: The Rise of Apolipoprotein C3 and Angiopoietin-Like Protein 3 Inhibitors. Am J Cardiovasc Drugs. 2025 Nov; 25(6):749-766.
-
Hypertriglyceridemia in New-Onset Type 1 Pediatric Diabetes. Pediatr Diabetes. 2025; 2025:8425032.
-
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and?Number?in?Hypertriglyceridemia. J Am Coll Cardiol. 2025 May 20; 85(19):1839-1854.
-
An overview of persistent chylomicronemia: much more than meets the eye. Curr Opin Endocrinol Diabetes Obes. 2025 Apr 01; 32(2):75-88.
-
Genetic Variants in Severe Hypertriglyceridemia Among Taiwanese Participants - Insights From Genome-Wide Association and Whole-Exome Sequencing Analyses. Circ J. 2025 Feb 25; 89(3):331-339.
-
Impact of Elevated Serum Triglycerides on Children with Acute Recurrent or Chronic Pancreatitis from INSPPIRE-2. J Pediatr. 2025 01; 276:114298.
-
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial. JAMA Cardiol. 2024 Jul 01; 9(7):620-630.